Les actualités

© 2023 Leila Ueberschlag

Enable: a tool to move from lab to licence

EPFL

The enable programme supports EPFL researchers who want to valorise the results of their research through licensing. Since its creation in 2012, more than 178 projects have been supported. Among these is a project aimed at finding a solution to the scourge of antibiotic resistance.

©iStock

New drug types can help counter antibiotic resistance

EPFL

EPFL scientists are developing a new approach that can help stem the tide of antibiotic resistance.

Emile de Rijk, CEO de SWISSto12 © Alain Herzog, EPFL

“When Switzerland put its mind to it, anything is possible”

EPFL

EPFL spin-off SWISSto12 has just signed a deal to supply a satellite to telecommunications service provider Intelsat. Here, we discuss this success story with CEO Emile de Rijk, who also shares his thoughts on what lies ahead for the Vaud-based company.

Retrouvez toutes les actualités
Inscrivez-vous et recevez un e-mail à chaque nouvelle publication